January 31, 2012 — At the upcoming February meeting of the Society for Cardiovascular Magnetic Resonance (SCMR) in Orlando, Fla. TomTec will introduce its 2-D Cardiac Performance Analysis magnetic resonance (MR) software product. The tool to quantify myocardial function and deformation based on regular cardiac magnetic resonance imaging (MRI).

2-D Cardiac Performance Analysis MR allows a cardiologist to study the function of the heart muscle quickly and easily. Quantification of displacement, velocity and strain in individual muscle segments help to assess hypertrophic cardiomyopathy or dyssynchrony of ventricles.

2-D Cardiac Performance Analysis MR is a feature tracking-based analysis tool that supports 2-D data from various cMR systems. It analyzes myocardial deformation in standard MR cine sequences and does not require specific acquisition modes like tagged imaging. Thus, already existing patient data can be used for follow-up comparisons.

“Based on its modern feature tracking algorithm, 2-D Cardiac Performance Analysis MR offers a robust and time-saving analysis of myocardial deformation and therefore meets all the conditions to be implemented in a clinical setting,” said Rolf Baumann, TomTec’s vice president of Clinical Products and Innovations.

The 2-D Cardiac Performance Analysis MR is not commercially available in the United States, awaiting U.S. Food and Drug Administration (FDA) 501(k) approval.   

For more information: www.tomtec.de


Related Content

News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
Subscribe Now